Renauld JC, Houssiau F, Louahed J et al. (1993). "Interleukin-9.". Adv. Immunol.54: 79–97. PMID8379467. doi:10.1016/S0065-2776(08)60533-7.CS1 održavanje: Eksplicitna upotreba et al. (link)
Knoops L, Renauld JC (2005). "IL-9 and its receptor: from signal transduction to tumorigenesis.". Growth Factors22 (4): 207–15. PMID15621723. doi:10.1080/08977190410001720879.
Modi WS, Pollock DD, Mock BA et al. (1991). "Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization.". Cytogenet. Cell Genet.57 (2-3): 114–6. PMID1680606. doi:10.1159/000133126.CS1 održavanje: Eksplicitna upotreba et al. (link)
Kelleher K, Bean K, Clark SC et al. (1991). "Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cells.". Blood77 (7): 1436–41. PMID1901233.CS1 održavanje: Eksplicitna upotreba et al. (link)
Holbrook ST, Ohls RK, Schibler KR et al. (1991). "Effect of interleukin-9 on clonogenic maturation and cell-cycle status of fetal and adult hematopoietic progenitors.". Blood77 (10): 2129–34. PMID1903074.CS1 održavanje: Eksplicitna upotreba et al. (link)
Merz H, Houssiau FA, Orscheschek K et al. (1991). "Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma.". Blood78 (5): 1311–7. PMID1908723.CS1 održavanje: Eksplicitna upotreba et al. (link)
Renauld JC, Goethals A, Houssiau F et al. (1990). "Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene.". J. Immunol.144 (11): 4235–41. PMID1971295.CS1 održavanje: Eksplicitna upotreba et al. (link)
Renauld JC, Goethals A, Houssiau F et al. (1991). "Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40.". Cytokine2 (1): 9–12. PMID2129501. doi:10.1016/1043-4666(90)90037-T.CS1 održavanje: Eksplicitna upotreba et al. (link)
Yang YC, Ricciardi S, Ciarletta A et al. (1989). "Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40.". Blood74 (6): 1880–4. PMID2508790.CS1 održavanje: Eksplicitna upotreba et al. (link)
Yin T, Keller SR, Quelle FW et al. (1995). "Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases.". J. Biol. Chem.270 (35): 20497–502. PMID7544789. doi:10.1074/jbc.270.35.20497.CS1 održavanje: Eksplicitna upotreba et al. (link)
Postma DS, Bleecker ER, Amelung PJ et al. (1995). "Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy.". N. Engl. J. Med.333 (14): 894–900. PMID7666875. doi:10.1056/NEJM199510053331402.CS1 održavanje: Eksplicitna upotreba et al. (link)
Le Beau MM, Espinosa R, Neuman WL et al. (1993). "Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.". Proc. Natl. Acad. Sci. U.S.A.90 (12): 5484–8. PMID8516290. doi:10.1073/pnas.90.12.5484.CS1 održavanje: Eksplicitna upotreba et al. (link)
Demoulin JB, Uyttenhove C, Van Roost E et al. (1996). "A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.". Mol. Cell. Biol.16 (9): 4710–6. PMID8756628.CS1 održavanje: Eksplicitna upotreba et al. (link)
Nicolaides NC, Holroyd KJ, Ewart SL et al. (1998). "Interleukin 9: a candidate gene for asthma.". Proc. Natl. Acad. Sci. U.S.A.94 (24): 13175–80. PMID9371819. doi:10.1073/pnas.94.24.13175.CS1 održavanje: Eksplicitna upotreba et al. (link)
Demoulin JB, Van Roost E, Stevens M et al. (1999). "Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9.". J. Biol. Chem.274 (36): 25855–61. PMID10464327. doi:10.1074/jbc.274.36.25855.CS1 održavanje: Eksplicitna upotreba et al. (link)
Lejeune D, Demoulin JB, Renauld JC (2001). "Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.". Biochem. J.353 (Pt 1): 109–116. PMID11115404. doi:10.1042/0264-6021:3530109.
Little FF, Cruikshank WW, Center DM (2001). "Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells.". Am. J. Respir. Cell Mol. Biol.25 (3): 347–52. PMID11588013.
Toda M, Tulic MK, Levitt RC, Hamid Q (2002). "A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma.". J. Allergy Clin. Immunol.109 (2): 246–50. PMID11842292. doi:10.1067/mai.2002.121555.
Pilette C, Ouadrhiri Y, Van Snick J et al. (2002). "IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta.". J. Immunol.168 (8): 4103–11. PMID11937570.CS1 održavanje: Eksplicitna upotreba et al. (link)